Changes in kinetic heterogeneity of breast cancer via computer-aided diagnosis on MRI predict the pathological response to neoadjuvant systemic therapy
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- EUROPEAN RADIOLOGY33(1) · pp.440 · 2023
- 피인용
- Web of Science 9Scopus 13
- FWCI (Scopus)
- 1.4
- JCR IF
- JCR 2022 5.9
- ISSN
- 0938-7994
저자
- 황보리제1저자Pusan Natl Univ, Pusan Natl Univ Hosp, Med Res Inst, Dept Radiol,Sch Med, 1-10 Ami Dong, Busan 602739, South Korea
- 김진유교신저자Pusan Natl Univ, Pusan Natl Univ Hosp, Med Res Inst, Dept Radiol,Sch Med, 1-10 Ami Dong, Busan 602739, South Korea
- 김진주Pusan Natl Univ, Pusan Natl Univ Hosp, Med Res Inst, Dept Radiol,Sch Med, 1-10 Ami Dong, Busan 602739, South Korea
- 이남경Pusan Natl Univ, Pusan Natl Univ Hosp, Med Res Inst, Dept Radiol,Sch Med, 1-10 Ami Dong, Busan 602739, South Korea
- 김석Pusan Natl Univ, Pusan Natl Univ Hosp, Med Res Inst, Dept Radiol,Sch Med, 1-10 Ami Dong, Busan 602739, South Korea
초록
Objective To evaluate whether the computer-aided diagnosis (CAD)-extracted kinetic heterogeneity of breast cancer on MRI and changes therein during treatment were associated with the pathological response to neoadjuvant systemic therapy (NST). Materials and methods Consecutive patients with invasive breast cancer, who underwent NST followed by surgery between 2014 and 2020, were retrospectively evaluated. Using a commercial CAD system, kinetic features (angiovolume, peak enhancement, delayed enhancement profiles, and kinetic heterogeneity) of breast cancer were assessed with pre- and mid-treatment MRI. Multivariate logistic regression was used to identify the associations between CAD-extracted kinetic features and pathological complete response (pCR). Results A total of 130 patients (mean age, 55 years) were included, 37 (28.5%) of whom achieved a pCR. When the pre- and mid-treatment MRI data were compared, the pCR group exhibited greater changes in kinetic heterogeneity (86.14 +/- 32.05% vs. 8.50 +/- 141.01%, p < 0.001) and angiovolume (95.20 +/- 14.29% vs. 19.89 +/- 320.16%; p < 0.001) than the non-pCR group. Multivariate regression analysis showed that a large change in kinetic heterogeneity (odds ratio (OR) = 1.030, p < 0.001), age (OR = 0.931, p = 0.005), progesterone receptor negativity (OR = 7.831, p = 0.001), and HER2 positivity (OR = 3.455, p = 0.017) were associated with pCR. Conclusions A greater change in the CAD-extracted kinetic heterogeneity of breast cancer between pre- and mid-treatment MRI was associated with a pCR in patients on NST.
키워드
Breast neoplasmsMagnetic resonance imagingNeoadjuvant therapyKineticsTreatment outcomeTEXTURE ANALYSISCONSERVING SURGERYCHEMOTHERAPYANGIOGENESISFEATURES
식별자
- Scopus EID
- 2-s2.0-85134489185
- WoS UID
- 000826810200001



로그인
연구물 목록으로